搜索
MapLight Therapeutics Inc
MPLT添加自选
28.730USD
-0.560-1.91%
收盘 05/15, 16:00（美东）报价延迟15分钟
1.26B总市值
亏损市盈率 TTM
关于 公司
MapLight Therapeutics Inc简介
公司代码- -
公司名称- -
上市日期- -
CEO- -
员工数量- -
证券类型- -
年结日- -
公司地址- -
城市- -
上市交易所- -
国家- -
邮编- -
电话- -
网址- -
公司代码- -
上市日期- -
CEO- -
MapLight Therapeutics Inc公司高管
名称
名称/职务
职务
持股
持股变动
Dr. Anatol Kreitzer, Ph.D.
Dr. Anatol Kreitzer, Ph.D.
Chief Discovery Officer
Chief Discovery Officer
211.19K
-23.08%
Mr. Jonathan Gillis, CPA
Mr. Jonathan Gillis, CPA
Chief Accounting Officer, Chief Administrative Officer
Chief Accounting Officer, Chief Administrative Officer
181.10K
-40.54%
Ms. Erin Pennock Foff, M.D., Ph.D.
Ms. Erin Pennock Foff, M.D., Ph.D.
Chief Medical Officer
Chief Medical Officer
10.16K
-538.62%
Mr. Vishwas Setia
Mr. Vishwas Setia
Chief Financial Officer
Chief Financial Officer
68.00
-53486.76%
Mr. Robert Malenka, M.D., Ph.D.
Mr. Robert Malenka, M.D., Ph.D.
Director
Director
--
--
Dr. Christopher A. Kroeger, M.D.
Dr. Christopher A. Kroeger, M.D.
Co-Founder, President, Chief Executive Officer, Director
Co-Founder, President, Chief Executive Officer, Director
--
--
Mr. James Lillie, Ph.D.
Mr. James Lillie, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
--
--
Mr. Kristopher L. Hanson
Mr. Kristopher L. Hanson
General Counsel
General Counsel
--
--
Dr. Timothy Garnett
Dr. Timothy Garnett
Independent Director
Independent Director
--
--
Ms. Nanna Luneborg, Ph.D.
Ms. Nanna Luneborg, Ph.D.
Independent Director
Independent Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Dr. Anatol Kreitzer, Ph.D.
Dr. Anatol Kreitzer, Ph.D.
Chief Discovery Officer
Chief Discovery Officer
211.19K
-23.08%
Mr. Jonathan Gillis, CPA
Mr. Jonathan Gillis, CPA
Chief Accounting Officer, Chief Administrative Officer
Chief Accounting Officer, Chief Administrative Officer
181.10K
-40.54%
Ms. Erin Pennock Foff, M.D., Ph.D.
Ms. Erin Pennock Foff, M.D., Ph.D.
Chief Medical Officer
Chief Medical Officer
10.16K
-538.62%
Mr. Vishwas Setia
Mr. Vishwas Setia
Chief Financial Officer
Chief Financial Officer
68.00
-53486.76%
Mr. Robert Malenka, M.D., Ph.D.
Mr. Robert Malenka, M.D., Ph.D.
Director
Director
--
--
Dr. Christopher A. Kroeger, M.D.
Dr. Christopher A. Kroeger, M.D.
Co-Founder, President, Chief Executive Officer, Director
Co-Founder, President, Chief Executive Officer, Director
--
--
收入明细
由于公司未披露，未能获取相关数据
由于公司未披露，未能获取相关数据
业务
地区
由于公司未披露，未能获取相关数据
股东统计
更新时间: 5月10日 周日
更新时间: 5月10日 周日
持股股东
股东类型
持股股东
持股股东
占比
Catalyst4 Inc
46.23%
Novo Holdings A/S
8.65%
Forbion Capital Partners
7.57%
T. Rowe Price Investment Management, Inc.
6.57%
Goldman Sachs & Company, Inc.
2.53%
其他
28.45%
持股股东
持股股东
占比
Catalyst4 Inc
46.23%
Novo Holdings A/S
8.65%
Forbion Capital Partners
7.57%
T. Rowe Price Investment Management, Inc.
6.57%
Goldman Sachs & Company, Inc.
2.53%
其他
28.45%
股东类型
持股股东
占比
Corporation
48.37%
Venture Capital
22.17%
Investment Advisor
17.23%
Investment Advisor/Hedge Fund
5.42%
Hedge Fund
3.74%
Individual Investor
3.29%
Research Firm
2.68%
Private Equity
1.42%
Endowment Fund
0.47%
机构持股
更新时间: 4月1日 周三
更新时间: 4月1日 周三
报告期
机构数
持股数
持股占比
持股变动
2026Q4
4
3.81M
0.06%
--
2026Q1
115
23.70M
55.61%
+17.80M
2025Q4
25
7.61M
16.77%
+7.34M
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Catalyst4 Inc
19.70M
46.42%
+19.70M
--
Oct 28, 2025
Novo Holdings A/S
3.69M
8.69%
--
--
Dec 31, 2025
Forbion Capital Partners
3.23M
7.6%
+1.80M
+126.19%
Dec 31, 2025
T. Rowe Price Investment Management, Inc.
2.80M
6.6%
+2.79M
+25926.78%
Dec 31, 2025
Goldman Sachs & Company, Inc.
1.08M
2.54%
+1.08M
--
Dec 31, 2025
BlackRock Institutional Trust Company, N.A.
1.01M
2.38%
+1.01M
--
Dec 31, 2025
Nan Fung Life Sciences
971.25K
2.29%
+971.25K
--
Dec 31, 2025
5AM Ventures
950.01K
2.24%
+950.01K
--
Dec 31, 2025
Sanofi SA
912.04K
2.15%
+912.04K
--
Dec 31, 2025
Goldman Sachs Asset Management, L.P.
859.35K
2.02%
+859.35K
--
Dec 31, 2025
查看更多
持股ETF
机构名称
占比
暂无数据
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
除权除息日
类型
比率
暂无数据
公告日期
除权除息日
类型
比率
暂无数据
